# A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Healthcare Professionals in Canada

> **NCT04567589** · — · WITHDRAWN · sponsor: **Allergan**

## Conditions studied

- Uterine Fibroids

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04567589
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-09-30
- **Primary completion:** 2021-02-28
- **Final completion:** 2021-02-28
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This study was cancelled before any data collection due to business reasons.
- **Last updated:** 2020-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04567589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04567589, "A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Healthcare Professionals in Canada". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04567589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*